Identifying patients harboring extended-spectrum-β-lactamase- producing enterobacteriaceae on hospital admission is not that simple

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 4, 2012, Pages 2218-2219

  Slekovec, Céline ^a   Bertrand, Xavier ^a   Leroy, Joël ^a   Faller, Jean Pierre ^b   Talon, Daniel ^a   Hocquet, Didier ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b Centre Hospitalier de Belfort Montbeliard   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; ENTEROBACTERIACEAE INFECTION; ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL ADMISSION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION CONTROL; INFECTION RISK; KLEBSIELLA; LETTER; NONHUMAN; PATIENT IDENTIFICATION; PRIORITY JOURNAL; PROTEUS; SCORING SYSTEM;

BETA-LACTAMASES; ENTEROBACTERIACEAE; FEMALE; HUMANS; MALE;

EID: 84858638273     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06376-11     Document Type: Letter

References (3)

1. Nordmann P, Naas T, Poirel L. 2011. Global spread of carbapenemase- producing Enterobacteriaceae. Emerg. Infect. Dis. 17:1791-1798.
2. Pitout JD. 2010. Infections with extended-spectrum β-lactamase- producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333.
3. Tumbarello M, et al. 2011. Identifying patients harboring extended-spectrum-β-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system. Antimicrob. Agents Chemother. 55:3485-3490.